Financhill
Sell
26

MATW Quote, Financials, Valuation and Earnings

Last price:
$23.12
Seasonality move :
3.45%
Day range:
$22.93 - $23.34
52-week range:
$21.09 - $32.24
Dividend yield:
4.22%
P/E ratio:
30.15x
P/S ratio:
0.41x
P/B ratio:
1.74x
Volume:
504K
Avg. volume:
270K
1-year change:
-22%
Market cap:
$719.1M
Revenue:
$1.8B
EPS (TTM):
-$1.99

Earnings Data

Next earnings date for MATW
May 02
2025
Most recent earnings per share
-$0.11
Missed by $0.34
(Feb 6/2025)
Consensus Estimate
$0.23
(Feb 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MATW Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/02/2025 Q1 $435.6M -- -- $0.38 --
02/06/2025 Q4 $426.9M $401.8M -$0.11 $0.23 -$0.34
11/21/2024 Q3 $440.5M $446.7M -$2.23 $0.38 -$2.61
08/01/2024 Q2 $450.1M $427.8M $0.06 $0.56 -$0.50
05/02/2024 Q1 $474.5M $471.2M $0.29 $0.46 -$0.17
02/01/2024 Q4 $451.9M $450M -$0.07 $0.47 -$0.54
11/16/2023 Q3 -- -- $0.56 $0.82 -$0.26
07/27/2023 Q2 -- -- $0.28 $0.66 -$0.38
04/27/2023 Q1 -- -- $0.29 $0.52 -$0.23
01/26/2023 Q4 -- -- $0.12 $0.50 -$0.38
11/17/2022 Q3 -- -- -$2.67 $0.72 -$3.39
07/28/2022 Q2 -- -- $0.09 $0.57 -$0.48
04/28/2022 Q1 -- -- -$0.06 $0.69 -$0.75
01/27/2022 Q4 -- -- -$0.62 $0.58 -$1.20
11/18/2021 Q3 -- -- -$0.12 $0.75 -$0.87
07/29/2021 Q2 -- -- $0.10 $0.75 -$0.65
04/29/2021 Q1 -- -- $0.16 $0.75 -$0.59
01/28/2021 Q4 -- -- -$0.06 $0.43 -$0.49
11/19/2020 Q3 -- -- $0.23 $0.85 -$0.62
07/30/2020 Q2 -- -- $0.07 $0.64 -$0.57
05/07/2020 Q1 -- -- -$2.77 $0.51 -$3.28
01/30/2020 Q4 -- -- -$0.34 $0.45 -$0.79
11/21/2019 Q3 -- -- -$2.28 $0.98 -$3.26
08/01/2019 Q2 -- -- $0.46 $0.94 -$0.48
05/02/2019 Q1 -- -- $0.48 $0.95 -$0.47
01/31/2019 Q4 -- -- $0.10 $0.55 -$0.45
11/15/2018 Q3 -- -- $0.92 $1.21 -$0.29
07/26/2018 Q2 -- -- $0.77 -- --
04/26/2018 Q1 -- -- $0.57 -- --
01/25/2018 Q4 -- -- $1.10 -- --
11/16/2017 Q3 -- -- $0.60 -- --
07/27/2017 Q2 -- -- $0.91 -- --
04/28/2017 Q1 -- -- $0.46 -- --
01/26/2017 Q4 -- -- $0.32 -- --
11/21/2016 Q3 -- -- $0.74 -- --
07/29/2016 Q2 -- -- $0.73 -- --
04/28/2016 Q1 -- -- $0.43 -- --
01/28/2016 Q4 -- -- $0.14 -- --
11/16/2015 Q3 -- -- $0.51 -- --
07/30/2015 Q2 -- -- $0.70 -- --
04/21/2015 Q1 -- -- $0.27 -- --

Matthews International Earnings Questions

  • How Much did Matthews International Generate in Revenue Last Quarter?

    Matthews International reported $401.8M worth of top line sales in its most recent quarter.

  • Did Matthews International Beat Earnings Last Quarter?

    Matthews International announced earnings per share of -$0.11 which represents a miss of analyst forecast a $0.23 per share.

  • Is Matthews International Profitable?

    Matthews International reported $125.7M that represents $4.04 per share over the last quarter.

  • What is the Analyst Consensus for Matthews International EPS Next Year?

    Matthews International's earnings are forecast to grow from -$1.93 per share to $2.00 per share next year representing an increase of 58.33%.

  • When is Matthews International's Earnings Date?

    Matthews International's next earnings date is May 2, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Sportradar Stock Going Up?
Why Is Sportradar Stock Going Up?

Sportradar (NASDAQ:SRAD) should be on your radar for a stock…

Is Roblox Stock a Buy, Sell or Hold?
Is Roblox Stock a Buy, Sell or Hold?

Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock